Israel’s baffling medical cannabis reforms are taking the initial steps towards creating order within the cannabis industry. Nevertheless, a comprehensive set of hopeful improvements has already been put in place. Which is intended to regulate how marijuana plants are grown, stored, packaged, distributed and as well dispensed. Although, despite the countries intentions. The Ministry of Health and local drug companies are particularly overlooking the the crucial findings from Israel’s very own homegrown medical cannabis research. To emphasize. In other words, the reform’s already causing an uproar from existing patients.
Israel’s Baffling Medical Cannabis Reforms
In April 2018. The Israeli Ministry of Health launched a pilot program in unison with a larger program of improvements in place. The pilot program’s intended to standardize the industry and reduce administration for the already 30,000+ patients using medical cannabis. The initial steps for the program begin with new practices of how and where the medical cannabis will be sold. And also how much the cannabis will be sold for. Along with a completely different pricing guide.
Up until recently. Medical cannabis patients had a more personal relationship with the growers with whom they received their bud from. Growers knew what the patient required for their ailments. And specifically prescribed them a strain support their needs. Also ideal was the price. About $100. Regardless of usage. Under the new laws and regulations. Medical patients must purchase their marijuana from authorized drug stores at set prices. 10 grams will run the patient about $40. For some. This new pricing spectrum is ideal. However, for those patients requiring a large amount of marijuana. Unfortunately, the new program may make treatment impossible.
First off, the most baffling part of all this is the standardization. The attempt to control. Define and dispense marijuana medicine based on a set THC:CBD ratio. Did Israel forget Israeli scientists discovered the entourage effect in Israel? Crazy how government officials try to control everything with their own rules! Not long ago in Globes, the Israeli financial newspaper. Yossi Bornstein, the founder of Cann10. A management system with several interests in the marijuana industry. Has stated that with the new laws and regulations. Marijuana will soon become a regulated drug. Although, the founder acknowledges that their are indeed more questions arising from the new laws. Rather than answers. Patients shouldn’t worry as the new rules are not set in stone. And may ultimately change as they do not meet everyones needs.
Comparatively, alongside the new set THC:CBD ratios comes new issues. Strains must be crossbred to uniquely achieve the specific proportions set forth. Try keeping up with all those new terpenes and their medicinal properties. As well the effects on individual patients. In the meantime. Drug stores are being stocked with a product called Axiban. A new line a marijuana oils. Noted by their THC:CBD content. It’s no doubt that many patients aren’t welcoming the reform with welcome arms. As their quality of life. And all in all, their literal life.
Families Speaking Out
So far, across Israels main media outlets. Patients and also their families across the country are speaking out against the new system. To demonstrate, the mother of a child who uses marijuana to treat his epilepsy and Autism. Called a popular Israeli radio station to appeal to the Ministry of Health over reconsidering the reforms over explicit extreme danger. In early June the Ministry of Health and the Unit for Medical Cannabis have scheduled an emergency meeting after obvious such appeals were made. So far, numerous Government officials. The Medical Cannabis Associations and as well patients rights groups have been invited to attend. In conclusion, fingers are crossed Israel’s Baffling Medical Cannabis Reforms change for the better.